Development and Validation of Enzyme‐Linked Immunosorbent Assays for Quantification of Anti‐Methotrexate IgG and Fab in Mouse and Rat Plasma

References

• 2003 . Facts and Figures: 2003 Atlanta : American Cancer Society . American Cancer Society
   Google Scholar
• Luce , T. L. , Dow , K. H. and Holcomb , L. 2003 . Early diagnosis key to epithelial ovarian cancer detection . Nurse Pract. , 28 ( 12 ) : 41 – 47 . [PUBMED] [INFOTRIEVE]
   PubMedGoogle Scholar
• Goel , R. , Cleary , S. M. , Horton , C. , Balis , F. M. , Zimm , S. , Kirmani , S. and Howell , S. B. 1989 . Selective intraperitoneal biochemical modulation of methotrexate by dipyridamole . J. Clin. Oncol. , 7 ( 2 ) : 262 – 269 . [PUBMED] [INFOTRIEVE]
   PubMedGoogle Scholar
• Dedrick , R. L. , Myers , C. E. , Bungay , P. M. and DeVita , V. T. 1978 . Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer . Cancer Treat. Rep. , 62 ( 1 ) : 1 – 11 . [PUBMED] [INFOTRIEVE]
   PubMedGoogle Scholar
• Howell , S. B. , Pfeifle , C. E. and Olshen , R. A. 1984 . Intraperitoneal chemotherapy with melphalan . Ann. Int. Med. , 101 ( 1 ) : 14 – 18 . [PUBMED] [INFOTRIEVE]
   PubMedGoogle Scholar
• Howell , S. B. , Chu , B. B. , Wung , W. E. , Metha , B. M. and Mendelsohn , J. 1981 . Long‐duration intracavity infusion of methotrexate with systemic leucovorin protection in patients with malignant effusions . J. Clin. Invest. , 67 ( 4 ) : 1161 – 1170 . [PUBMED] [INFOTRIEVE]
   PubMedGoogle Scholar
• Howell , S. B. , Pfeifle , C. L. , Wung , W. E. , Olshen , R. A. , Lucas , W. E. , Yon , J. L. and Green , M. 1982 . Intraperitoneal cisplatin with systemic thiosulfate protection . Ann. Int. Med. , 97 ( 6 ) : 845 – 851 . [PUBMED] [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Speyer , J. L. , Collins , J. M. , Dedrick , R. L. , Brennan , M. F. , Buckpitt , A. R. , Londer , H. , Devita , V. T. and Myers , C. E. 1980 . Phase I and pharmacological studies of 5‐flurouracil administered intraperitoneally . Cancer Res. , 40 ( 3 ) : 306 – 311 .
   Google Scholar
• Pfeiffer , P. , Bennedback , O. and Bertelsen , K. 1990 . Intraperitoneal carboplatin in the treatment of minimal residual ovarian cancer . Gynecol. Oncol. , 36 ( 3 ) : 1035 – 1043 . [CROSSREF]
   Google Scholar
• Balthasar , J. P. and Fung , H. L. 1994 . Utilization of antidrug antibody fragments for the optimization of intraperitoneal drug therapy: studies using digoxin as a model drug . J. Pharmacol. Exp. Ther. , 268 ( 2 ) : 734 – 739 . [PUBMED] [INFOTRIEVE] [CSA]
   PubMedGoogle Scholar
• Balthasar , J. P. and Fung , H. L. 1996 . Inverse targeting of peritoneal tumors: selective alteration of the disposition of methotrexate through the use of anti‐methotrexate antibodies and antibody fragments . J. Pharm. Sci. , 85 ( 10 ) : 1035 – 1043 .
   PubMedGoogle Scholar
• Balthasar , J. P. and Fung , H. L. 1995 . High‐affinity rabbit antibodies directed against methotrexate: production, purification, characterization and pharmacokinetics in the rat . J. Pharm. Sci. , 84 ( 1 ) : 2 – 6 . [PUBMED] [INFOTRIEVE]
   PubMedGoogle Scholar
• Harlow , E. and Lane , D. 1988 . “ Appendix II: protein techniques ” . In Antibodies: A Laboratory Manual 673 New York : Cold Spring Harbor Laboratory .
   Google Scholar
• Bazin Redureau , M. I. , Renard , C. B. and Scherrman , J. M. 1997 . Pharmacokinetics of heterologous and homologous immunoglobulin G, F(ab′)2 and Fab after intravenous administration in the rat . J. Pharm. Pharmacol. , 49 ( 3 ) : 277 – 281 . [PUBMED] [INFOTRIEVE]
   PubMedGoogle Scholar
• Caballero , F. , Pelegri , C. , Castell , M. , Franch , A. and Castellote , C. 1998 . Kinetics of W3/25 anti‐rat CD4 monoclonal antibody. Studies on optimal doses and time‐related effects . Immunopharmacology , 39 ( 2 ) : 83 – 91 . [PUBMED] [INFOTRIEVE] [CROSSREF] [CSA]
   PubMedGoogle Scholar